4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-032312
Executive VP, Head of R&D sold 6,700 shares at an average $70.13 ($469,884)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Tony W Executive VP, Head of R&D | 2020-05-22 | Sale | −600 | $70.05 | $42,030 | 47,005 | D: show line 1 in the form |
| Ho Tony W Executive VP, Head of R&D | 2020-05-26 | Sale | −6,100 | $70.14 | $427,854 | 40,905 | D: show line 2 in the form |
| Open-market sales · 6,700 sh · avg $70.13 · $469,884 | |||||||
Loading xslF345X03/doc4.xml…